Research article · Dec 2015
Conference abstractPublished 10 Aug 2023
Application of Phenotype Microarray in lung cancer after treatment with cisplatin
PSMMC, Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The phenotype microarray (PM) technique provide a high-throughput for characterization the phenotyping of cells. This technique use a redox dye, employing cell respiration (NADH production) as a universal cell based reporter. The dyes used in Biolog assays measure output of NADH production from different catabolic pathways present in the cells being tested. Figure 1. shows the layout of the carbon sources in the PM-M1 microplate. PM method applied to examine the effect of cisplatin, a chemotherapy drug, treatment on the metabolic rate in lung cancer cells produced by different substrates. The H1299 and A549 human lung cancer cell lines were tested by using standard protocols for metabolic PM mammalian cell assays. Dye reduction was calculated from A590-A750 values measured from microplate wells after 6 h from addition of MA dye. Paired t tests from univariate analysis were adjusted. In H1299 cells, there was a reduction in metabolism of dextrin, maltotriose, D-maltose, D-glucose-1-phosphate, and inosine (Figure 2) following treatment with cisplatin. In A549 cells, there was also a reduction in metabolism of substrates such as D-trehalose, D-glucose-6-phosphate and D-glucose-1-phosphate (Figure 3). The uridine, pyruvic acid and ketoglutaric acid were metabolised significantly in A549 cells after treatment with cisplatin in comparison with H1299 cells (Figure 2, 3). Adenosine substrate in the phenotype microarray plate do not appear to be useful as carbon sources in both cells. Treatment of the lung cancer cells with cisplatin produced a different effect on the H1299 cells in comparison with the A549 cells. There was more reduction in carbon metabolism in H1299 cells, but in the A549 cells the metabolism was not that strongly affected and the cells continued to produce NADH. Therefore, there may be differences in the mechanisms by which the two types of lung cancer cells respond to cisplatin treatment, which could lead to different mechanisms of cell death induced by the anticancer activity. The mechanism of necrosis and other cell death pathways may have significant difference between human lung cancer cell lines.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 23 Oct 2017
Non-small cell lung (NSCL) cancer search for biomarkers from body fluids to microarrays
Conference abstract · 2017
Comparison of efficacy and toxicity of carboplatin or cisplatin based chemo-radiotherapy treatment among elderly locally advanced non-small cell lung cancer patients
Conference abstract · 11 Nov 2019
Application of meaning-centered group psychotherapy in patients with lung cancer: A randomized controlled trial
Conference abstract · 2018
The application of Huaxi emotional-distress index in the investigation of emotional disorder in patients with lung cancer
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Sanad Mohammed Alonezi”
